세계의 의약품용 멤브레인 필터 시장 (~2029년) : 제품별 (필터 (PES, PVDF, 나일론), 시스템 (일회용)), 기술별 (정밀 여과, 한외 여과), 용도별 (API, 백신), 종류별 (멸균, 비멸균), 운영 규모별

■ 영문 제목 : Pharmaceutical Membrane Filtration Market by Product (Filters (PES, PVDF, Nylon), Systems (Single use)), Technique (Microfiltration, Ultrafiltration), Application (API, Vaccines), Type (Sterile, Non Sterile), Scale of Operation - Global Forecast to 2029

MarketsandMarkets 회사가 출판한 조사자료로, 코드는 BT2255-24 입니다.■ 상품코드 : BT2255-24
■ 조사/발행회사 : MarketsandMarkets
■ 발행일 : 2024년 3월
■ 페이지수 : 477
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : Email (주문후 24시간내 납품)
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 의료
■ 판매가격 / 옵션 (부가세 10% 별도)
Single UserUSD4,950 ⇒환산￦6,930,000견적의뢰/주문/질문
Multi User (Five User)USD6,650 ⇒환산￦9,310,000견적의뢰/주문/질문
Corporate LicenseUSD8,150 ⇒환산￦11,410,000견적의뢰/구입/질문
※가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
"세계의 의약품용 멤브레인 필터 시장 규모는 2024년 10.6억 달러에서 2029년 19.6억 달러에 달할 것으로 예상되며, 2024~2029년 예측 기간 동안 연평균 13.1%의 성장률을 기록할 것으로 예상됩니다." 이 시장의 성장은 최종 사용 산업에서 순도에 대한 요구가 증가했기 때문입니다. 생명과학 산업에서 초순수는 유전체학, 단백질학, 면역학, 약리학, 세포 및 조직 배양, 신약개발에 필수적입니다. 생명과학 연구에서 타입 I, 초순수 또는 연구용 물의 수요가 증가함에 따라 순수 실험실 물 공급은 실험실 산업에서 가장 중요하고 빠르게 성장하는 시장 중 하나가 되었습니다. 이러한 추세는 향후 몇 년 동안 의약품용 멤브레인 필터 시장의 성장을 촉진할 것으로 예상됩니다.

"2023년 무균 여과 부문이 유형별 최대 점유율을 차지할 것으로 예상됩니다."
2023년 글로벌 의약품용 멤브레인 필터 시장에서 무균 여과 부문이 유형별로 가장 큰 점유율을 차지할 것으로 예상됩니다. 무균 여과는 미생물을 제거하는 과정으로 최종 제품의 무균성을 보장하는 데 중요한 역할을 합니다. 무균 필터는 액체 의약품의 중간 및 최종 여과에 널리 사용됩니다. 규제 당국에 따르면 의약품의 최종 제품 가공에는 무균 등급 필터가 필요하며 최종 제품 가공에서 가장 중요합니다. 또한 무균 필터는 비무균 필터에 비해 여러 가지 장점이 있어 제약 및 바이오 제약 산업의 상류 및 하류 공정에서 선호되고 있습니다.

"2024년에서 2029년 까지 예측 기간 동안 미국이 의약품용 멤브레인 필터 시장을 계속 지배할 것으로 예측됩니다."
2023년 북미 의약품용 멤브레인 필터 시장은 미국이 주도할 것으로 예상됩니다. 미국은 세계 최대 바이오 의약품 시장이자 바이오 의약품 연구/투자 분야의 선두주자입니다. 또한 미국에는 하버드대학교, 스탠포드대학교, 매사추세츠공과대학(MIT) 등 세계 최고의 학술 연구기관이 있습니다. 이들 연구소에서는 신약개발, 유전체, 생명공학 등 생명과학 분야에서 최첨단 연구가 진행되고 있으며, 막여과 제품의 사용이 요구되고 있습니다. 여과막의 기술 발전과 특허의 증가는 제약 및 생명공학 산업에서의 여과 채택을 촉진하고 있습니다.

본 보고서를 위해 실시한 1차 인터뷰는 다음과 같이 분류됩니다.
- 응답자별 : 공급측 70%, 수요측 30%.
- 직급별 : 관리자 : 45%, CXO 및 이사 : 30%, 임원 : 25%.
- 지역별 : 북미 40%, 유럽 25%, 아시아 태평양 20%, 중남미 10%, 중동/아프리카 5%.

보고서 수록 기업 목록
　Thermo Fisher Scientific Inc. (US)
　Merck KGaA (Germany)
　Danaher Corporation (US)
　Sartorius AG (Germany)
　Thermo Fisher Scientific, Inc. (US)
　3M Company (US)
　Parker Hannifin Corporation (US)
　Repligen Corporation (US)
　Asahi Kasei Corporation (Japan)
　Eaton Corporation plc (Ireland)
　GEA Group (Germany)
　Corning Incorporated (US)
　Alfa Laval Corporate AB (Sweden)
　Donaldson Company, Inc. (US)
　Saint-Gobain (France)
　MANN+HUMMEL International GmbH & Co. KG (Germany)
　Meissner Filtration Products, Inc. (US)
　Cole-Parmer Instrument Company, LLC (US)
　Applexion (France)
　Cantel Medical Corp. (US)
　W. L. Gore & Associates Inc. (US)
　Membrane Solutions (US)
　Amazon Filters Ltd. (UK)
　Toyo Roshi Kaisha, Ltd. (Japan)
　Porvair plc (UK)
　Sterlitech Corporation (US)
　Synder Filtration, Inc. (US)
　Graver Technologies, LLC (US)
　Koch Membrane Systems, Inc. (US)
　Nupore Filtration Systems (India)
　Cobetter Filtration Equipment Co., Ltd. (China)

조사 범위
본 조사 보고서는 의약품용 멤브레인 필터 시장을 제품별(멤브레인 필터, 시스템, 기타 제품), 기술별(정밀 여과, 한외 여과, 나노 여과, 기타 기술), 용도별(최종 제품 가공, 원료 여과, 세포 분리, 정수, 공기 정화), 유형별(무균 여과, 비무균 여과), 운영 규모별(제조 규모, 파일럿 규모 운영, 연구개발 규모 운영), 지역별(북미, 유럽, 아시아 태평양, 중남미, 중동, 아프리카)로 분류하고 있습니다. 의약품용 멤브레인 필터 시장의 성장에 영향을 미치는 촉진 요인, 저해 요인, 도전 과제, 기회 등 주요 요인에 대한 자세한 정보를 다룹니다. 주요 산업 플레이어를 자세히 분석하고 사업 개요, 제품, 솔루션, 주요 전략, 제휴, 파트너십, 계약에 대한 통찰력을 제공합니다.

보고서 구매의 주요 이점
이 보고서는 전체 의약품용 멤브레인 필터 시장과 그 하위 부문의 수익에 대한 가장 근접한 추정치를 제공함으로써 시장 리더와 신규 진입자에게 도움이 될 것입니다. 또한 이해관계자들이 경쟁 현황을 더 잘 이해하고, 비즈니스 포지셔닝을 개선하고, 적절한 시장 진입 전략을 수립할 수 있는 통찰력을 얻을 수 있도록 돕습니다. 이 보고서는 이해관계자들이 시장의 맥박을 이해하고 주요 시장 동인, 저해 요인, 기회, 도전 과제에 대한 정보를 제공할 수 있도록 돕습니다.

이 보고서는 다음과 같은 사항에 대한 통찰력을 제공합니다.
- 시장 성장에 영향을 미치는 주요 촉진 요인(일회용 기술 채택 증가, 엄격한 규제 요건, 제약 및 생명공학 산업의 R&D 비용 증가, 최종 용도 산업의 순도 요건 증가), 저해 요인(막 오염 문제, 중소기업의 진입을 제한하는 높은 자본 투자 요건), 기회(신흥국에서의 기회 증가, 나노 여과 기술 발전), 도전 과제(비용 증가, 필터 속도 및 수율 감소) 등을 분석합니다.
- 제품 개발/혁신 : 의약품용 멤브레인 필터 시장의 신규 출시 제품에 대한 상세한 통찰력을 제공합니다.
- 시장 개발 : 유리한 시장에 대한 포괄적인 정보 - 이 보고서는 다양한 지역의 시장을 분석합니다.
- 시장 다각화 : 의약품용 멤브레인 필터 시장의 신제품, 미개척 지역, 최근 개발 및 투자에 대한 상세 정보를 제공합니다.
- 경쟁사 평가 : Merck KGaA (Germany), Danaher Corporation (US), Sartorius AG (Germany), Thermo Fisher Scientific, Inc. (US), 3M Company (US), Parker Hannifin Corporation (US), Repligen Corporation (US), Asahi Kasei Corporation (Japan), Eaton Corporation plc (Ireland), GEA Group (Germany), Corning Incorporated (US), Alfa Laval Corporate AB (Sweden), Donaldson Company, Inc. (US) 등의 기업 정보를 포함합니다.
■ 보고서 개요

1 서론
2 조사 방법
3 개요
4 프리미엄 인사이트
5 시장 개요
6 세계의 의약품용 멤브레인 필터 시장 규모 : 제품별
7 세계의 의약품용 멤브레인 필터 시장 규모 : 기술별
8 세계의 의약품용 멤브레인 필터 시장 규모 : 응용 분야별
9 세계의 의약품용 멤브레인 필터 시장 규모 : 종류별
10 세계의 의약품용 멤브레인 필터 시장 규모 : 운영 규모별
11 세계의 의약품용 멤브레인 필터 시장 규모 : 지역별
12 경쟁 현황
13 기업 정보
14 부록

■ 보고서 목차

1 INTRODUCTION 68
1.1 STUDY OBJECTIVES 68
1.2 MARKET DEFINITION 68
1.2.1 INCLUSIONS AND EXCLUSIONS OF STUDY 69
1.3 STUDY SCOPE 70
1.3.1 MARKET SEGMENTATION 70
1.3.2 REGIONS COVERED 71
1.4 YEARS CONSIDERED 71
1.5 CURRENCY 72
1.6 STAKEHOLDERS 72
1.7 LIMITATIONS 72
1.8 SUMMARY OF CHANGES 73
1.9 RECESSION IMPACT 74
2 RESEARCH METHODOLOGY 75
2.1 RESEARCH DATA 75
FIGURE 1 RESEARCH DESIGN 75
2.1.1 SECONDARY DATA 76
2.1.2 PRIMARY DATA 77
FIGURE 2 BREAKDOWN OF PRIMARIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET 77
2.2 MARKET ESTIMATION METHODOLOGY 78
FIGURE 3 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SIZE ESTIMATION (SUPPLY-SIDE ANALYSIS), 2023 78
2.2.1 BOTTOM-UP APPROACH 78
FIGURE 4 MARKET SIZE ESTIMATION: APPROACH 1 (COMPANY REVENUE ANALYSIS-BASED ESTIMATION), 2023 79
FIGURE 5 REVENUE SHARE ANALYSIS: ILLUSTRATIVE EXAMPLE OF SARTORIUS AG (2023) 79
2.2.2 INSIGHTS FROM PRIMARY EXPERTS 81
FIGURE 6 MARKET SIZE VALIDATION FROM PRIMARY SOURCES 81
2.2.3 TOP-DOWN APPROACH 81
FIGURE 7 MARKET SIZE ESTIMATION METHODOLOGY: TOP-DOWN APPROACH 81
2.3 GROWTH FORECAST 82
FIGURE 8 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: CAGR PROJECTIONS 83
2.4 MARKET BREAKDOWN AND DATA TRIANGULATION 84
FIGURE 9 DATA TRIANGULATION METHODOLOGY 84
2.5 RESEARCH ASSUMPTIONS 85
2.6 MARKET FORECAST 85
TABLE 1 FACTOR ANALYSIS 85
2.7 RISK ANALYSIS 86
2.8 RECESSION IMPACT ANALYSIS 86
3 EXECUTIVE SUMMARY 88
FIGURE 10 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2024 VS. 2029 (USD MILLION) 88
FIGURE 11 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2024 VS. 2029 (USD MILLION) 89
FIGURE 12 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2024 VS. 2029 (USD MILLION) 90
FIGURE 13 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TYPE, 2024 VS. 2029 (USD MILLION) 91
FIGURE 14 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY SCALE OF OPERATION, 2024 VS. 2029 (USD MILLION) 91
FIGURE 15 GEOGRAPHICAL SNAPSHOT OF PHARMACEUTICAL MEMBRANE FILTRATION MARKET 92
4 PREMIUM INSIGHTS 94
4.1 PHARMACEUTICAL MEMBRANE FILTRATION MARKET OVERVIEW 94
FIGURE 16 RISING R&D SPENDING IN PHARMACEUTICAL AND BIOTECHNOLOGY INDUSTRIES TO DRIVE MARKET GROWTH 94
4.2 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT AND COUNTRY (2023) 95
FIGURE 17 MEMBRANE FILTERS SEGMENT ACCOUNTED FOR LARGEST SHARE OF NORTH AMERICAN PHARMACEUTICAL MEMBRANE FILTRATION MARKET IN 2023 95
4.3 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SHARE, BY APPLICATION, 2024 VS. 2029 95
FIGURE 18 FINAL PRODUCT PROCESSING SEGMENT TO DOMINATE MARKET IN 2029 95
4.4 PHARMACEUTICAL MEMBRANE FILTRATION MARKET SHARE, BY TECHNIQUE, 2023 96
FIGURE 19 MICROFILTRATION SEGMENT ACCOUNTED FOR LARGEST MARKET SHARE IN 2023 96
4.5 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: GEOGRAPHIC GROWTH OPPORTUNITIES 97
FIGURE 20 ASIA PACIFIC COUNTRIES TO REGISTER HIGHEST GROWTH RATE FROM 2024 TO 2029 97
5 MARKET OVERVIEW 98
5.1 INTRODUCTION 98
5.2 MARKET DYNAMICS 98
FIGURE 21 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: DRIVERS, RESTRAINTS, OPPORTUNITIES, AND CHALLENGES 98
TABLE 2 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: IMPACT ANALYSIS 99
5.2.1 DRIVERS 99
5.2.1.1 Increasing adoption of single-use technologies 99
5.2.1.2 Stringent regulatory requirements 100
5.2.1.3 Rising R&D spending in pharmaceutical and biotechnology industries 100
FIGURE 22 PHARMACEUTICAL R&D SPENDING, 2014–2028 (USD BILLION) 101
5.2.1.4 Increasing purity requirements in end-use industries 101
5.2.2 RESTRAINTS 102
5.2.2.1 Membrane fouling issues 102
5.2.2.2 High capital investment requirements to limit entry of smaller players 102
5.2.3 OPPORTUNITIES 103
5.2.3.1 Growth opportunities in emerging economies 103
5.2.3.2 Advances in nanofiltration technology 103
5.2.4 CHALLENGES 104
5.2.4.1 Increased cost and reduced speed & yield of filters 104
5.3 TECHNOLOGY ANALYSIS 104
TABLE 3 TECHNOLOGY ANALYSIS 104
5.4 SUPPLY CHAIN ANALYSIS 105
FIGURE 23 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: SUPPLY CHAIN ANALYSIS 105
5.5 VALUE CHAIN ANALYSIS 106
FIGURE 24 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: VALUE CHAIN ANALYSIS 107
5.6 ECOSYSTEM ANALYSIS 108
FIGURE 25 PHARMACEUTICAL MEMBRANE FILTRATION MARKET ECOSYSTEM 108
5.6.1 PHARMACEUTICAL MEMBRANE FILTRATION RAW MATERIAL SUPPLIERS 109
TABLE 4 PHARMACEUTICAL MEMBRANE FILTRATION RAW MATERIAL SUPPLIERS 109
5.6.2 PHARMACEUTICAL MEMBRANE FILTRATION VENDORS 109
TABLE 5 PHARMACEUTICAL MEMBRANE FILTRATION VENDORS 109
5.6.3 PHARMACEUTICAL MEMBRANE FILTRATION END USERS 110
TABLE 6 PHARMACEUTICAL MEMBRANE FILTRATION END USERS 110
5.6.4 PHARMACEUTICAL MEMBRANE FILTRATION REGULATORY BODIES 111
TABLE 7 PHARMACEUTICAL MEMBRANE FILTRATION REGULATORY BODIES 111
5.7 TRENDS/DISRUPTIONS IMPACTING CUSTOMER’S BUSINESS 111
FIGURE 26 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: TRENDS/DISRUPTIONS IMPACTING CLIENT’S BUSINESS 111
5.8 PRICING ANALYSIS 113
TABLE 8 AVERAGE SELLING PRICE OF KEY PLAYERS, BY PRODUCT 113
5.8.1 AVERAGE SELLING PRICE RANGE, BY REGION, 2023 113
TABLE 9 AVERAGE SELLING PRICE, BY REGION, 2023 113
5.9 REGULATORY LANDSCAPE 114
5.9.1 REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 114
TABLE 10 NORTH AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 114
TABLE 11 EUROPE: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 115
TABLE 12 ASIA PACIFIC: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 115
TABLE 13 LATIN AMERICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 116
TABLE 14 MIDDLE EAST & AFRICA: REGULATORY BODIES, GOVERNMENT AGENCIES, AND OTHER ORGANIZATIONS 116
5.9.2 REGULATORY SCENARIO IN DIFFERENT COUNTRIES 117
5.10 PATENT ANALYSIS 118
5.10.1 METHODOLOGY 118
5.10.2 PATENTS FILED, BY DOCUMENT TYPE, 2013–2023 118
TABLE 15 PATENTS FILED, 2013–2023 118
5.10.3 INNOVATION AND PATENT APPLICATIONS 118
FIGURE 27 TOTAL NUMBER OF PATENTS GRANTED, 2014–2023 118
5.10.4 TOP APPLICANTS 119
FIGURE 28 TOP TEN PLAYERS WITH HIGHEST NUMBER OF PATENT APPLICATIONS, 2014–2023 119
TABLE 16 TOP 20 PATENT OWNERS IN PHARMACEUTICAL MEMBRANE FILTRATION MARKET, 2014–2023 119
TABLE 17 PATENTS IN PHARMACEUTICAL MEMBRANE FILTRATION MARKET, 2023 120
5.11 INVESTMENT/FUNDING ACTIVITIES 121
5.12 KEY CONFERENCES AND EVENTS, 2024 122
TABLE 18 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: DETAILED LIST OF CONFERENCES AND EVENTS, 2024 122
5.13 PORTER’S FIVE FORCES ANALYSIS 123
TABLE 19 PHARMACEUTICAL MEMBRANE FILTRATION MARKET: PORTER’S FIVE FORCES ANALYSIS 123
5.13.1 THREAT OF NEW ENTRANTS 123
5.13.2 THREAT OF SUBSTITUTES 123
5.13.3 BARGAINING POWER OF BUYERS 124
5.13.4 BARGAINING POWER OF SUPPLIERS 124
5.13.5 INTENSITY OF COMPETITIVE RIVALRY 124
5.14 KEY STAKEHOLDERS AND BUYING CRITERIA 125
5.14.1 KEY STAKEHOLDERS IN BUYING PROCESS 125
FIGURE 29 INFLUENCE OF STAKEHOLDERS ON BUYING PROCESS OF PHARMACEUTICAL MEMBRANE FILTRATION PRODUCTS 125
5.14.2 KEY BUYING CRITERIA FOR PHARMACEUTICAL MEMBRANE FILTRATION PRODUCTS AMONG END USERS 125
FIGURE 30 KEY BUYING CRITERIA FOR END USERS 125
TABLE 20 BUYING CRITERIA FOR PHARMACEUTICAL MEMBRANE FILTRATION, BY END USER 126
5.15 CASE STUDY ANALYSIS 127
5.15.1 CASE STUDY 1: PELLICON 2 CASSETTE PROCESSING OF THERAPEUTIC PROTEINS 127
5.15.2 CASE STUDY 2: FILTER HOUSING CAPABLE OF HANDLING BOTH GAS AND LIQUID 127
5.15.3 CASE STUDY 3: 3M OFFERS EMPHAZE AEX HYBRID PURIFIER TO REDUCE IMPURITIES IN BIOPHARMACEUTICAL DOWNSTREAM PROCESS 127
5.15.4 CASE STUDY 4: DELIVERY OF POLYPROPYLENE PLEATED CARTRIDGES FOR HIGH-PURITY PHARMACEUTICAL PRODUCTS 128
5.15.5 CASE STUDY 5: USE OF POLYPROPYLENE HIGH-FLOW CARTRIDGE FOR FINAL FILTRATION PROCESS 128
6 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT 129
6.1 INTRODUCTION 130
TABLE 21 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY PRODUCT, 2022–2029 (USD MILLION) 130
6.2 MEMBRANE FILTERS 130
TABLE 22 PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY TYPE, 2022–2029 (USD MILLION) 131
TABLE 23 PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 132
TABLE 24 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 132
TABLE 25 EUROPE: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 133
TABLE 26 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 133
TABLE 27 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 134
TABLE 28 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 134
TABLE 29 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 134
6.2.1 POLYETHERSULFONE MEMBRANE FILTERS 135
6.2.1.1 Wide use of hydrophilic PES membranes in sterilizing applications to drive growth 135
TABLE 30 POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 135
TABLE 31 NORTH AMERICA: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 32 EUROPE: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 136
TABLE 33 ASIA PACIFIC: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 34 LATIN AMERICA: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 137
TABLE 35 MIDDLE EAST: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 138
TABLE 36 GCC COUNTRIES: POLYETHERSULFONE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 138
6.2.2 POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS 138
6.2.2.1 Non-toxic, highly pure, and biologically safe—advantages supporting market growth 138
TABLE 37 POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 139
TABLE 38 NORTH AMERICA: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 139
TABLE 39 EUROPE: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 40 ASIA PACIFIC: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 140
TABLE 41 LATIN AMERICA: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 141
TABLE 42 MIDDLE EAST: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 141
TABLE 43 GCC COUNTRIES: POLYVINYLIDENE DIFLUORIDE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 141
6.2.3 NYLON MEMBRANE FILTERS 142
6.2.3.1 Increased endotoxin adsorption capacity to drive growth 142
TABLE 44 NYLON MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 142
TABLE 45 NORTH AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 142
TABLE 46 EUROPE: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 47 ASIA PACIFIC: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 143
TABLE 48 LATIN AMERICA: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 144
TABLE 49 MIDDLE EAST: NYLON MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 144
TABLE 50 GCC COUNTRIES: NYLON MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 144
6.2.4 POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS 145
6.2.4.1 PTFE membrane filters offer retention of ratings as fine as 0.01μ 145
TABLE 51 POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 145
TABLE 52 NORTH AMERICA: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 145
TABLE 53 EUROPE: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 146
TABLE 54 ASIA PACIFIC: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 146
TABLE 55 LATIN AMERICA: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 147
TABLE 56 MIDDLE EAST: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 147
TABLE 57 GCC COUNTRIES: POLYTETRAFLUOROETHYLENE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 147
6.2.5 MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS 148
6.2.5.1 Provide optically compatible surface for greater adsorption of products 148
TABLE 58 MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 148
TABLE 59 NORTH AMERICA: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 60 EUROPE: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 149
TABLE 61 ASIA PACIFIC: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 150
TABLE 62 LATIN AMERICA: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 150
TABLE 63 MIDDLE EAST: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 151
TABLE 64 GCC COUNTRIES: MIXED CELLULOSE ESTER & CELLULOSE ACETATE MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 151
6.2.6 POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS 151
6.2.6.1 Widely used in cell biology and analytical testing applications 151
TABLE 65 POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 152
TABLE 66 NORTH AMERICA: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 152
TABLE 67 EUROPE: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 68 ASIA PACIFIC: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 153
TABLE 69 LATIN AMERICA: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 154
TABLE 70 MIDDLE EAST: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 154
TABLE 71 GCC COUNTRIES: POLYCARBONATE TRACK-ETCHED MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 154
6.2.7 OTHER MEMBRANE FILTERS 155
TABLE 72 OTHER MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 156
TABLE 73 NORTH AMERICA: OTHER MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 156
TABLE 74 EUROPE: OTHER MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 157
TABLE 75 ASIA PACIFIC: OTHER MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 157
TABLE 76 LATIN AMERICA: OTHER MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 158
TABLE 77 MIDDLE EAST: OTHER MEMBRANE FILTERS MARKET, BY REGION, 2022–2029 (USD MILLION) 158
TABLE 78 GCC COUNTRIES: OTHER MEMBRANE FILTERS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 158
6.3 SYSTEMS 159
TABLE 79 PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY TYPE, 2022–2029 (USD MILLION) 159
TABLE 80 PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 160
TABLE 81 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 160
TABLE 82 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 83 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 161
TABLE 84 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 162
TABLE 85 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 162
TABLE 86 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 162
6.3.1 SINGLE-USE SYSTEMS 163
6.3.1.1 Reduced need for product validation and minimized cross-contamination risk to boost adoption 163
TABLE 87 SINGLE-USE SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 163
TABLE 88 NORTH AMERICA: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 164
TABLE 89 EUROPE: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 164
TABLE 90 ASIA PACIFIC: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 165
TABLE 91 LATIN AMERICA: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 165
TABLE 92 MIDDLE EAST: SINGLE-USE SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 165
TABLE 93 GCC COUNTRIES: SINGLE-USE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 166
6.3.2 REUSABLE SYSTEMS 166
6.3.2.1 Widely used for large-scale manufacturing 166
TABLE 94 REUSABLE SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 166
TABLE 95 NORTH AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 96 EUROPE: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 167
TABLE 97 ASIA PACIFIC: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 168
TABLE 98 LATIN AMERICA: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 168
TABLE 99 MIDDLE EAST: REUSABLE SYSTEMS MARKET, BY REGION, 2022–2029 (USD MILLION) 168
TABLE 100 GCC COUNTRIES: REUSABLE SYSTEMS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 169
6.4 OTHER PRODUCTS 169
TABLE 101 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY TYPE, 2022–2029 (USD MILLION) 169
TABLE 102 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY REGION, 2022–2029 (USD MILLION) 170
TABLE 103 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION) 170
TABLE 104 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION) 171
TABLE 105 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION) 171
TABLE 106 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION) 172
TABLE 107 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY REGION, 2022–2029 (USD MILLION) 172
TABLE 108 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER PRODUCTS, BY COUNTRY, 2022–2029 (USD MILLION) 172
6.4.1 MEMBRANE FILTRATION ASSEMBLIES 173
6.4.1.1 Leading players provide pre-assembled filtration assemblies 173
TABLE 109 MEMBRANE FILTRATION ASSEMBLIES MARKET, BY REGION, 2022–2029 (USD MILLION) 173
TABLE 110 NORTH AMERICA: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 173
TABLE 111 EUROPE: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 174
TABLE 112 ASIA PACIFIC: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 174
TABLE 113 LATIN AMERICA: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 175
TABLE 114 MIDDLE EAST: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY REGION, 2022–2029 (USD MILLION) 175
TABLE 115 GCC COUNTRIES: MEMBRANE FILTRATION ASSEMBLIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 175
6.4.2 ACCESSORIES 176
6.4.2.1 Increasing adoption of pharmaceutical membrane filtration products to support growth 176
TABLE 116 PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION) 176
TABLE 117 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 176
TABLE 118 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 177
TABLE 119 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 177
TABLE 120 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 178
TABLE 121 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY REGION, 2022–2029 (USD MILLION) 178
TABLE 122 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION ACCESSORIES MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 178
7 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE 179
7.1 INTRODUCTION 180
TABLE 123 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY TECHNIQUE, 2022–2029 (USD MILLION) 180
7.2 MICROFILTRATION 180
7.2.1 AVAILABILITY OF INNOVATIVE AND COST-EFFECTIVE MICROFILTRATION MEMBRANES TO SUPPORT MARKET GROWTH 180
TABLE 124 PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 181
TABLE 125 NORTH AMERICA: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 181
TABLE 126 EUROPE: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 182
TABLE 127 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 182
TABLE 128 LATIN AMERICA: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 183
TABLE 129 MIDDLE EAST: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 183
TABLE 130 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE MICROFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 183
7.3 ULTRAFILTRATION 184
7.3.1 LEAST COSTLY TECHNIQUE TO OPERATE 184
TABLE 131 PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 184
TABLE 132 NORTH AMERICA: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 185
TABLE 133 EUROPE: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 185
TABLE 134 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 186
TABLE 135 LATIN AMERICA: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 186
TABLE 136 MIDDLE EAST: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 187
TABLE 137 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE ULTRAFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 187
7.4 NANOFILTRATION 187
7.4.1 HIGH ENERGY CONSUMPTION TO HINDER MARKET GROWTH 187
TABLE 138 PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 188
TABLE 139 NORTH AMERICA: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 188
TABLE 140 EUROPE: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 189
TABLE 141 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 189
TABLE 142 LATIN AMERICA: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 190
TABLE 143 MIDDLE EAST: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 190
TABLE 144 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE NANOFILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 190
7.5 OTHER TECHNIQUES 191
TABLE 145 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY REGION, 2022–2029 (USD MILLION) 191
TABLE 146 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 191
TABLE 147 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 192
TABLE 148 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 192
TABLE 149 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 193
TABLE 150 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY REGION, 2022–2029 (USD MILLION) 193
TABLE 151 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR OTHER TECHNIQUES, BY COUNTRY, 2022–2029 (USD MILLION) 193
8 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION 194
8.1 INTRODUCTION 195
TABLE 152 PHARMACEUTICAL MEMBRANE FILTRATION MARKET, BY APPLICATION, 2022–2029 (USD MILLION) 195
8.2 FINAL PRODUCT PROCESSING 195
TABLE 153 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY TYPE, 2022–2029 (USD MILLION) 196
TABLE 154 PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY REGION, 2022–2029 (USD MILLION) 196
TABLE 155 NORTH AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2022–2029 (USD MILLION) 197
TABLE 156 EUROPE: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2022–2029 (USD MILLION) 197
TABLE 157 ASIA PACIFIC: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2022–2029 (USD MILLION) 198
TABLE 158 LATIN AMERICA: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2022–2029 (USD MILLION) 198
TABLE 159 MIDDLE EAST: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY REGION, 2022–2029 (USD MILLION) 199
TABLE 160 GCC COUNTRIES: PHARMACEUTICAL MEMBRANE FILTRATION MARKET FOR FINAL PRODUCT PROCESSING, BY COUNTRY, 2022–2029 (USD MILLION) 199
8.2.1 ACTIVE PHARMACEUTICAL INGREDIENT (API) FILTRATION 199
8.2.1.1 Continuous requirement for API filtration to drive market 199
TABLE 161 ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 200
TABLE 162 NORTH AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 200
TABLE 163 EUROPE: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 201
TABLE 164 ASIA PACIFIC: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 201
TABLE 165 LATIN AMERICA: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 202
TABLE 166 MIDDLE EAST: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY REGION, 2022–2029 (USD MILLION) 202
TABLE 167 GCC COUNTRIES: ACTIVE PHARMACEUTICAL INGREDIENT FILTRATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 202
8.2.2 PROTEIN PURIFICATION 203
8.2.2.1 Advancements in protein therapeutic drugs to propel growth 203
TABLE 168 PROTEIN PURIFICATION MARKET, BY REGION, 2022–2029 (USD MILLION) 203
TABLE 169 NORTH AMERICA: PROTEIN PURIFICATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 204
TABLE 170 EUROPE: PROTEIN PURIFICATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 204
TABLE 171 ASIA PACIFIC: PROTEIN PURIFICATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 205
TABLE 172 LATIN AMERICA: PROTEIN PURIFICATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 205
TABLE 173 MIDDLE EAST: PROTEIN PURIFICATION MARKET, BY REGION, 2022–2029 (USD MILLION) 205
TABLE 174 GCC COUNTRIES: PROTEIN PURIFICATION MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 206
8.2.3 VACCINE AND ANTIBODY PROCESSING 206
8.2.3.1 Rising investments in life science R&D to drive growth 206
TABLE 175 VACCINE AND ANTIBODY PROCESSING MARKET, BY REGION, 2022–2029 (USD MILLION) 206
TABLE 176 NORTH AMERICA: VACCINE AND ANTIBODY PROCESSING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 207
TABLE 177 EUROPE: VACCINE AND ANTIBODY PROCESSING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 207
TABLE 178 ASIA PACIFIC: VACCINE AND ANTIBODY PROCESSING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 208
TABLE 179 LATIN AMERICA: VACCINE AND ANTIBODY PROCESSING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 208
TABLE 180 MIDDLE EAST: VACCINE AND ANTIBODY PROCESSING MARKET, BY REGION, 2022–2029 (USD MILLION) 209
TABLE 181 GCC COUNTRIES: VACCINE AND ANTIBODY PROCESSING MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 209
8.2.4 FORMULATION AND FILLING SOLUTIONS 209
8.2.4.1 Demand for aseptic filling and bioburden reduction to propel growth 209
TABLE 182 FORMULATION AND FILLING SOLUTIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 210
TABLE 183 NORTH AMERICA: FORMULATION AND FILLING SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 210
TABLE 184 EUROPE: FORMULATION AND FILLING SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 211
TABLE 185 ASIA PACIFIC: FORMULATION AND FILLING SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 211
TABLE 186 LATIN AMERICA: FORMULATION AND FILLING SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 212
TABLE 187 MIDDLE EAST: FORMULATION AND FILLING SOLUTIONS MARKET, BY REGION, 2022–2029 (USD MILLION) 212
TABLE 188 GCC COUNTRIES: FORMULATION AND FILLING SOLUTIONS MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 212
8.2.5 VIRAL CLEARANCE 213
8.2.5.1 Development of therapeutic monoclonal antibodies to drive market 213
TABLE 189 VIRAL CLEARANCE MARKET, BY REGION, 2022–2029 (USD MILLION) 213
TABLE 190 NORTH AMERICA: VIRAL CLEARANCE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 214
TABLE 191 EUROPE: VIRAL CLEARANCE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 214
TABLE 192 ASIA PACIFIC: VIRAL CLEARANCE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 215
TABLE 193 LATIN AMERICA: VIRAL CLEARANCE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 215
TABLE 194 MIDDLE EAST: VIRAL CLEARANCE MARKET, BY REGION, 2022–2029 (USD MILLION) 215
TABLE 195 GCC COUNTRIES: VIRAL CLEARANCE MARKET, BY COUNTRY, 2022–2029 (USD MILLION) 216

보고서 이미지

※본 조사보고서 [세계의 의약품용 멤브레인 필터 시장 (~2029년) : 제품별 (필터 (PES, PVDF, 나일론), 시스템 (일회용)), 기술별 (정밀 여과, 한외 여과), 용도별 (API, 백신), 종류별 (멸균, 비멸균), 운영 규모별] (코드 : BT2255-24) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 의약품용 멤브레인 필터 시장 (~2029년) : 제품별 (필터 (PES, PVDF, 나일론), 시스템 (일회용)), 기술별 (정밀 여과, 한외 여과), 용도별 (API, 백신), 종류별 (멸균, 비멸균), 운영 규모별] 에 대해서 E메일 문의는 여기를 클릭하세요.
*** 아래는 관련 보고서 소개입니다 ***

  • 세계의 첨단 창상 치료 시장 (~2027년) : 제품별 (드레싱 (폼, 하이드로콜로이드, 필름, 알긴산), NPWT, 괴사조직 제거 기기, 이식편, 매트릭스, 국소 약물), 창상 종류별 (수술, 외상, 궤양, 화상), 최종 용도별 (병원, 재택 의료)
    MD3838-23 / MarketsandMarkets / 2023년 1월 / MarketsandMarkets사는 세계의 첨단 창상 치료 시장 규모가 2022년 113억 달러에서 2027년 177억 달러에 이르며, 예측 기간 동안 연평균 9.4%로 성장할 것으로 추정하고 있습니다. 본 조사 리포트는 세계의 첨단 창상 치료...“The advanced wound care market is valued at an estimated USD 11.3 billion in 2022 and is projected to reach USD 17.7 billion by 2027, at a CAGR of 9.4% during the forecast period. ” The rising prevalence of diseases and ailments that impair the ability to heal wounds as...
  • 세계의 생검 기기 시장 (~2028년) : 제품별 (침생검, 흡인 생검, 진공 지원 생검), 용도별 (유방 생검, 폐 생검, 전립선 생검), 지침별 (정위 생검, 초음파), 최종 용도별 (병원), 지역별
    MD5504-23 / MarketsandMarkets / 2023년 10월 / "세계의 생검 기기 시장은 2023년 66억 달러에서 2028년 126억 달러에 이르며, 연평균 성장률은 14.0%로 전망됩니다."암 및 기타 만성 질환의 이환율 증가와 같은 요인은 더 빈번하고 정확한 조직 샘플링의 필요성에 박차를...1. 소개 2. 조사 방법 3. 개요 4. 프리미엄 인사이트 5. 시장 개요 6. 세계의 생검 기기 시장 분석 : 제품별 7. 세계의 생검 기기 시장 분석 : 지침 기술별 8. 세계의 생검 기기 시장 분석 : 용도별 9. 세계의 생검 기기 시장 분석 : 최종 용도별 10. 세계의 생검...
  • 세계의 MRI 시스템 시장 (~2028년) : 구조별 (개방형, 폐쇄형), 자기장 세기별 (중저자장 (1.5T, 3T), 고자장 및 초고자장 (4T 이상)), 용도별 (신경, 척수, 골반, 유방, 심장 질환), 최종 용도별
    MD3220-23 / MarketsandMarkets / 2023년 11월 / "세계의 MRI 시스템 시장은 2023년 52억 달러에서 2028년 66억 달러에 이르며, 같은 기간동안 연평균 성장률은 5.0%가 될 전망입니다."MRI 시스템의 채용 확대와 아기 부머 인구의 증가 등의 요인이 이 시장의 성장...1. 소개 2. 조사 방법 3. 개요 4. 프리미엄 인사이트 5. 시장 개요 6. 세계의 MRI 시스템 시장 분석 : 자기장 강도별 7. 세계의 MRI 시스템 시장 분석 : 구조별 8. 세계의 MRI 시스템 시장 분석 : 용도별 9. 세계의 MRI 시스템 시장 분석 : 최종 용도별 10. 세계의 MRI...
  • 세계의 치과용 3D 프린팅 시장 (~2029년) : 3D 스캐너, 프린터
    MD6394-24 / MarketsandMarkets / 2024년 2월 / "세계의 치과용 3D 프린팅 시장은 2023년 29억 달러에서 2029년 81억 달러로 연평균 19.0% 성장할 것으로 예상됩니다." 3D 프린팅 하드웨어, 소프트웨어 및 재료 개발의 지속적인 발전으로 정확도, 속도 및 가격이 향상되어...1 서론 2 조사 방법 3 개요 4 프리미엄 인사이트 5 시장 개요 6 세계의 치과용 3D 프린팅 시장 규모 : 제품 및 서비스별 7 세계의 치과용 3D 프린팅 시장 규모 : 기술별 8 세계의 치과용 3D 프린팅 시장 규모 : 용도별 9 세계의 치과용 3D 프린팅 시장 규모 :...
  • 세계의 정신 건강 스크리닝 시장 (~2029년) : 질환별 (우울증, 양극성 장애, 조현병, ADHD, 알츠하이머, 치매), 검진별 (자가, 면담, 관찰, 바이오 마커), 기술별 (mHealth, 원격 플랫폼, 원격 의료), 연령별, 설정별
    HIT8966-24 / MarketsandMarkets / 2024년 3월 / "세계의 정신 건강 스크리닝 시장은 2023년 9억 달러에서 2029년 18억 달러로 확대될 것으로 예상되며, 예측 기간 동안 12.2%의 CAGR을 기록할 것으로 예상됩니다." 정신 건강 문제에 대한 인식 증가, 노인 인구의...1 서론 2 조사 방법 3 개요 4 프리미엄 인사이트 5 시장 개요 6 세계의 정신 건강 스크리닝 시장 규모 : 용도별 7 세계의 정신 건강 스크리닝 시장 규모 : 검진 방법별 8 세계의 정신 건강 스크리닝 시장 규모 : 기술별 9 세계의 정신 건강 스크리닝 시장 규모 : 연령대별...

    • ※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!